Discovered monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
He discovered two significant conditions, monoclonal gammopathy of undetermined
significance and smoldering multiple myeloma, laying the groundwork to understand
myeloma disease progression.
Much of the knowledge that exists today in medicine about myeloma and monoclonal
abnormalities, as well as the reputation Mayo Clinic has gained as one of the best medical
centers in the world for myeloma research and treatment, is due to his work.
In 2001, he was the first recipient of the Waldenstrom Award for understanding and
treatment of Waldenstrom macroglobulinemia.
Has gained recognition the world over as a pioneer and a respected leader in the
advancement of research, clinical treatment, and education about this insidious cancer
of the plasma cells in the bone marrow.
In 2003, the Robert A. Kyle Lifetime Achievement Award was established to "honor the
physician who most exemplifies a singular dedication to and compassion for myeloma
patients and treatment of their disease."